February 2024 - Page 11 of 19

WednesdayFeb 14, 2024 11:25 am

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Opens Up Access to the Newest Advantage2(TM) Prototype

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in the development and delivery of quantum computing systems, software and services and the world’s first commercial supplier of quantum computers, has announced that the Advantage2 prototype, which features 1,200+ qubits and 10,000+ couplers, is now available via the company’s LeapTM real-time quantum cloud service. According to D-Wave, customers with Leap service subscriptions can access the new Advantage2 prototype today. Those new to the Leap service can sign up and get up to one minute of free use of the actual quantum processing units (“QPUs”) and quantum hybrid solvers, including the new Advantage2 prototype. “Today marks…

WednesdayFeb 14, 2024 10:41 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Financial Numbers for Q2 2024, Corporate Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting on its financial results for Q2 2024, the period ended Dec. 31, 2023. The company also provided a corporate update, including plans to advance two preclinical programs in Alzheimer's and age-related macular degeneration. Highlights of the report included that the company closed the 2023 calendar year in a cash position of $9.5 million and with 164% revenue growth in business subsidiary, BayMedica. “This period was another strong operational quarter for the company, as we expanded our pharmaceutical pipeline with…

WednesdayFeb 14, 2024 9:45 am

Turbo Energy (NASDAQ: TURB) Drives AI Innovation within Residential Energy Storage Solutions

Artificial Intelligence is expected to both, drive global energy consumption whilst simultaneously, increasing the efficiency of global power usage Turbo Energy is seeking to harness artificial intelligence in the manufacture and development of their residential energy solutions, which allow households to capture and store solar energy The Company has recently entered into an agreement with Solar360, the energy-focused subsidiary of Repsol and Telefonica, in a move to dramatically increase their distribution footprint The growing demands of artificial intelligence (“AI”) are set to drive a sharp increase in data center storage capacity, with the latter expected to grow from 10.1 zettabytes…

WednesdayFeb 14, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks off 2024 with FDA IND Submission for its HYPER-H23-1 Phase 1b Human Clinical Trial

Lexaria, a global innovator in drug delivery platforms, just announced the submission of its IND application with the FDA for its HYPER-H23-1 phase 1b hypertension clinical trial This study will seek to evaluate the safety and tolerability of Lexaria’s patented DehydraTECH(TM) technology, specifically DehydraTECH-CBD, in hypertensive patients Lexaria expects to build on success of its previous studies, which showed positive results and DehydraTECH-CBD’s potential to have broad therapeutic utility Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the submission of its much-anticipated Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”)…

WednesdayFeb 14, 2024 3:52 am

QualityStocksNewsBreaks – Rocket Lab USA Inc. (NASDAQ: RKLB) Closes on $355M Private Offering

Rocket Lab USA (NASDAQ: RKLB), a global leader in launch services and space systems, has closed on its private offering. The transaction was a $355 million principal amount of 4.250% convertible senior notes due 2029; the notes are due to those reasonably believed to be qualified institutional buyers. According to the announcement, the total amount of the offering comes from both the previously announced, upsized offering of $300 million combined with the full exercise of the $55 million option to purchase additional notes, which Rocket Lab granted to initial purchasers of the notes. The company anticipates using funds from the…

TuesdayFeb 13, 2024 3:35 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases Financial Report, Company Update on ‘Strongest Quarter to Date’

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting financial results for the three months ended Dec. 31, 2023; the company is also reporting a business update. Highlights of the report included the company regaining compliance with the NASDAQ minimum-bid price requirement in January; the achievement of several key milestones, including CARB and federal EPA and NHTSA certification for its Class 1 and Class 3 vehicles, as well as IRS approval as a “qualified manufacturer”; the completion of its lightweight service truck body for the All-Electric Mullen THREE; the submission of a preapplication to the U.S. Department…

TuesdayFeb 13, 2024 2:33 pm

QualityStocksNewsBreaks — Vision Marine Technologies Inc. (NASDAQ: VMAR) Names MarineMax Executive to Board

Vision Marine Technologies (NASDAQ: VMAR), a global leader and innovator within the performance electric recreational boating industry, announced that Anthony E. Cassella Jr., executive vice president finance and chief accounting officer at MarineMax Inc. (NYSE: HZO) has been appointed to its board of directors; Cassella will serve as an independent director. According to the announcement, the appointment reflects VMAR’s leading role in marine technology innovation and underscores its commitment to strong corporate governance; the company noted that the veteran’s background and industry knowledge “will bring incredible value to the next chapter of Vision Marine's mission to become the leading provider…

TuesdayFeb 13, 2024 2:16 pm

QualityStocksNewsBreaks – Renovaro Inc. (NASDAQ: RENB) Fusing AI and Biotech to Accelerate Personalized Medicine, GEDiCube, Cyclomics Enter LOI to ‘Change the Field’

Renovaro (NASDAQ: RENB) today announced the completion of its acquisition of GEDi Cube Intl Ltd. (“GEDiCube”). Renovaro, which means renew, combines the power of the AI Health Tech platform of GEDiCube with the advanced cell and gene-therapy Biotech platform of Renovaro Biosciences to accelerate precision, personalized medicine, marking a new era in healthcare innovation. According to the announcement, the two subsidiaries will be under the parent organization, which was renamed Renovaro Inc. “We believe this combination marks a significant milestone in the journey of personalized medicine,” said Renovaro’s CEO Mark Dybul, MD. “Together, we believe that we are poised to…

TuesdayFeb 13, 2024 2:08 pm

QualityStocksNewsBreaks – GEMXX Corp. (GEMZ) Announces Groundbreaking Start for January Product Deliveries

GEMXX (OTC: GEMZ), a pioneering mine-to-market gold, gemstone and jewelry producer, today announced a stellar start to the year with impressive product deliveries worth $1,051,374 at retail for the month of January. According to the announcement, January’s deliveries mark an incredible 600% increase compared to the same period last year, highlighting GEMXX's strong growth trajectory and its effective business strategies. “Our January delivery results are a testament to the hard work and dedication of the GEMXX team,” said Jay Maull, CEO of GEMXX Corporation. “Our ability to achieve such significant deliveries is a clear indication of our competitive edge in…

TuesdayFeb 13, 2024 2:01 pm

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Appoints Liat Halpert as Head of Business Development, Sales

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit, today announced the appointment of Liat Halpert as head of business development and sales. Halpert brings extensive pharmaceutical sales and marketing experience and joins Scinai following 14 years at Novartis, most recently having served as marketing and commercial excellence lead for cell and gene therapies for Central, Southern and Eastern Europe. “I am pleased to welcome Liat to Scinai,” said Amir Reichman, Scinai’s CEO. “Her pharmaceutical sales, marketing and leadership experience, in particular in…

Site Search

Company Search

Month: February 2024